Kangmei Pharmaceutical Co (SHSE:600518) Total Stockholders Equity : ¥7,055 Mil (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Kangmei Pharmaceutical Co Total Stockholders Equity?

Kangmei Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥7,055 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Kangmei Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥0.51. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Kangmei Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.04.

Kangmei Pharmaceutical Co Total Stockholders Equity Historical Data

The historical data trend for Kangmei Pharmaceutical Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kangmei Pharmaceutical Co Total Stockholders Equity Chart

Kangmei Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

20,515.27

-10,536.10

9,926.56

6,948.41

7,047.56

Kangmei Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															6,897.85	6,825.46	6,800.75	7,047.56	7,054.94

Kangmei Pharmaceutical Co (SHSE:600518) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Kangmei Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(7054.938	-	0)	/	13863.9
	=	0.51

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Kangmei Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(69.361	+	186.615)	/	7054.938
	=	0.04

Kangmei Pharmaceutical Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Kangmei Pharmaceutical Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Kangmei Pharmaceutical Co (SHSE:600518) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kangmei Pharmaceutical Co Ltd (SHSE:600518) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

N/A

Address

No. 3, Taike Road, Xiameilin, Futian District, Shenzhen, CHN, 518000

Website

http://www.kangmei.com.cn

Kangmei Pharmaceutical Co Ltd is a pharmaceutical company engaged in the manufacturing, research and marketing of herbal medicine and chemical raw materials.

Executives

Xu Dong Jin	Director
Li Jian Hua	senior management
Qiu Xi Wei	Director
Wang Min	senior management
Peng Qin	senior management
Ma Xing Tian	Director
Lin Guo Xiong	senior management
Zhuang Yi Qing	senior management
Wen Shao Sheng	Supervisors

Kangmei Pharmaceutical Co (SHSE:600518) Headlines

No Headlines